Apache II Score

APACHE II Score: Quantifies ICU illness severity using 12 physiologic variables plus age and chronic health status to predict hospital mortality 1 [Level I evidence].

Age
<44045-54+255-64+365-74+5>74+6
HO Orgn Dz/Decr Imm
No0Y: elective post-op pt+2Y: non-op or emerg post-op pt+5
Rectal Temp
36-38.4 C038.5-38.9 C+134-35.9 C+132-33.9 C+239-40.8 C+330-31.9 C+3<30 C+4>40.9 C+4
MAP
70-1090110-129+250-69+2130-159+3>159+4<50+4
HR Vent Response
70-1090110-139+255-69+2140-179+340-54+3>179+4<40+4
RR Non-vent/Vent
12-24025-34+110-11+16-9+235-49+3>49+4<6+4
A-a Grad
AaG <200 or pO2 >700pO2 61-70+1AaG 200-349+2AaG 350-499+3pO2 55-60+3AaG >499+4pO2 <55+4
Arterial pH
7.33-7.4907.50-7.59+17.25-7.32+27.60-7.69+37.15-7.24+3>7.69+4<7.15+4
Serum Na+
130-149 mMol/L0150-154 mMol/L+1120-129 mMol/L+2155-159 mMol/L+2160-179 mMol/L+3111-119 mMol/L+3<111 mMol/L+4>179 mMol/L+4
Serum K+
3.5-5.4 mMol/L05.5-5.9 mMol/L+13-3.4 mMol/L+12.5-2.9 mMol/L+26-6.9 mMol/L+3>6.9 mMol/L+4<2.5 mMol/L+4
Serum Cr
0.6-1.4 mg/100 ml01.5-1.9 mg/100 ml and chronic+2<0.6 mg/100 ml+22.0-3.4 mg/100 ml and chronic+3>3.4 mg/100 ml and chronic+41.5-1.9 mg/100 ml and acute+42.0-3.4 mg/100 ml and acute+6>3.4 mg/100 ml and acute+8
Hematocrit
30-45.9046-49.9+150-59.9+220-29.9+2<20+4>59.9+4
WBC
3-14.9015-19.9+11-2.9+220-39.9+2>39.9+4<1.0+4

Indications for Use

Start in critically ill adults in ICU within 24 hours of admission to quantify physiologic derangement and estimate mortality risk. APACHE II integrates acute physiology, age, and chronic health status and is most useful for benchmarking severity, guiding prognosis discussions, and comparing outcomes across ICUs. It is not intended for triage decisions or treatment selection. 1 [Level I evidence]

Insights & Cautions

Provides early mortality risk using acute physiologic derangements and chronic health status but should not guide treatment decisions.

  • Optimized for ICU populations; less reliable in ED or ward patients.
  • Influenced by transient abnormalities (eg, sedation, intubation).
  • Not for serial trend‑based decisions; changes may not reflect true clinical improvement.
  • Poor discrimination in specific conditions (eg, cirrhosis, immunosuppression).
  • Use only as adjunct, never as sole prognostic determinant.